Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Completed- Microfluidic systems for the study of neurotransmitters: NeuroTrans

This project is completed now. If interested, feel free to contact us.

Microfluidic systems for the study of neurotransmitters: introduction

nerves microfluidics neurotransmitters

Neurons interact and propagate signals by releasing small molecules called neurotransmitters, into the synaptic cleft (Fig. 1); the reuptake of these molecules is very fast (milliseconds) and is carried out by membrane proteins called neurotransporters.

 

Understanding how these membrane proteins interact with neurotransmitters and recreational drugs or new psychoactive substances (NPS), is a highly interesting and challenging task for scientists and biologists.

They are also interested in elucidating how their malfunction can be linked to diseases like Parkinson, epilepsy or seizures.

Studying neurotransmitters with microfluidics: project description

In the ITN consortium NeuroTrans, the Microfluidics Innovation Center will bring its expertise to develop a user-friendly microfluidic platform for cell culture on a chip that will allow multiple substrates to be tested simultaneously and offer real-time optical monitoring of cells in biocompatible conditions to elucidate neurotransmitter function.

Using the OB1 flow controller and the MUX injection valve (Elveflow), the perfusion system will provide temperature control, precise compound delivery, cell perfusion, and optical monitoring of cell growth.

Between 50 and 200 Novel Psychoactive Substances (NPS) appear each year on the illicit drug market. These substances compete with neurotransmitters to bind transporters, causing nonphysiological effects.


NPS is untested, neither for pharmacodynamic activity nor toxicological side-effects, creating a massive burden for society. Thorough and rapid characterization of NPS is, therefore, a top priority, both for healthcare professionals and policymakers.

We aim to develop a user-friendly microfluidic platform to characterize the mode of action of new psychoactive substances mimicking neurotransmitters.

This project will be undertaken in close collaboration with the Medical University of Vienna, in the group of Prof. Dr. Harald Sitte, Department of Pharmacology.

Neurotransmitters mode of action microfluidics
Figure 1: Process of chemical signal transmission in the synaptic cleft shown on two examples. neurotransmitters are being released into the synaptic cleft and bind to receptors of post-synaptic neurons; transporter proteins remove neurotransmitters from the synaptic cleft. Image source: Kristensen AS. et al, SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation. Pharmacological reviews. 2011.

Related content & results from this project

In the light of the NeuroTrans project, we have developed:

 

In addition, we published a review about deep learning and microfluidics and an application note on automated sample collection

Funding

This project has received funding from the European Union’s Horizon research and innovation program under the Marie Skłodowska-Curie grant agreement No 860954 (NeuroTrans project).

Researcher

Francesca_Brugnoli

Francesca Romana Brugnoli

Marie-Curie PhD Candidate Elvesys/MUW

  • M.Sc. Politecnico di Milano (Milan, Italy)
  • B.Sc. Sapienza University (Rome, Italy)

 

Areas of expertise:

Biomedical engineering, Microfluidics

Marie Curie Doctoral Networks 2024 Microfluidics Innovation Center

Funded by the EU

Check our Projects